Director of U.S. Programs
Oxitec Ltd
St Charles, Illinois, United States
Rajeev Vaidyanathan, Ph.D., completed his B.S. in entomology from Cornell University, his M.S. in entomology from UMASS-Amherst, and his Ph.D. in parasitology from the Hebrew University of Jerusalem – Hadassah Medical School. He completed postdocs in insect immunity at CNRS-Strasbourg, France, and in mosquito vector competence at UC-Davis. Rajeev was Associate Director of Vector Biology and Zoonotic Disease at SRI International, where he managed programs in novel target site validation for mosquito larvicides and adulticides and bed bug control in lower-income housing, resulting in patents for ectoparasite detection. He then served as Director of Entomology at Clarke Mosquito, where he was responsible for the validation of molecules from microbial, botanical, and invertebrate sources as novel active ingredients (AIs) in mosquito larvicides and adulticides. He has served as a medical entomology consultant for dozens of companies interested in commercializing new AIs for mosquito, black fly, tick, and bed bug control or repellence. He works with mosquito and vector control districts to assess, improve, and conduct mosquito surveillance and control, especially before and after natural disasters. As Director of U.S. Programs at Oxitec, he engages with key stakeholders to commercialize Oxitec Aedes aegypti to control this invasive species.
Disclosure information not submitted.
Innovative, Operational Non-Chemical Approaches to Mosquito Control Symposium I
Thursday, March 7, 2024
8:30am – 10:00am
Innovative, Operational Non-Chemical Approaches to Mosquito Control Symposium II
Thursday, March 7, 2024
10:45am – 12:15pm
235 - Scale-up of Oxitec’s Sustainable, Self-Limiting Solution for Aedes aegypti
Thursday, March 7, 2024
12:00pm – 12:15pm